“Machine Learning-Driven Pharmacovigilance Models for Drug-Induced Liver Injury (DILI) Risk Prediction and Personalized Therapeutic Dose Optimization in Chronic Liver Disease Patients”. 2026. The Science Post 2 (3). https://www.thesciencepostjournal.com/index.php/tsp/article/view/254.